SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-177704
Filing Date
2022-06-21
Accepted
2022-06-21 16:37:15
Documents
12
Period of Report
2022-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d352729d8k.htm   iXBRL 8-K 29738
  Complete submission text file 0001193125-22-177704.txt   155363

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cdak-20220617.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdak-20220617_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdak-20220617_pre.xml EX-101.PRE 11713
6 EXTRACTED XBRL INSTANCE DOCUMENT d352729d8k_htm.xml XML 3465
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39615 | Film No.: 221028626
SIC: 2836 Biological Products, (No Diagnostic Substances)